Alpha1-antitrypsin deficiency: An analysis of patient subgroups of the German registry

C. Guttmann, P. M. Lepper, M. Bachhuber, C. Herr, A. R. Koczulla, C. Vogelmeier, R. Bals (Homburg, Marburg, Germany)

Source: Annual Congress 2011 - COPD mechanisms
Session: COPD mechanisms
Session type: Thematic Poster Session
Number: 3596
Disease area: Airway diseases

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
C. Guttmann, P. M. Lepper, M. Bachhuber, C. Herr, A. R. Koczulla, C. Vogelmeier, R. Bals (Homburg, Marburg, Germany). Alpha1-antitrypsin deficiency: An analysis of patient subgroups of the German registry. Eur Respir J 2011; 38: Suppl. 55, 3596

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Alpha1-antitrypsin deficiency in Italy: Analysis of the Italian registry database
Source: Annual Congress 2011 - Respiratory epidemiology: genetics and modifiable risk factors
Year: 2011


Clinical phenotypes of Italian and Spanish patients with a1-antitrypsin deficiency
Source: Eur Respir J 2013; 42: 54-64
Year: 2013



Differences of disease phenotypes in individuals with alpha-1-antitrypsin deficiency with genotypes PiZZ and PiSZ - Analysis from the German registry
Source: International Congress 2016 – Phenotyping and monitoring airway diseases
Year: 2016

The prevalence of diagnosed ?1-antitrypsin deficiency and its comorbidities: results from a large population-based database
Source: Eur Respir J 2017; 49(1): 1600154; DOI: 10.1183/13993003.00154-2016
Year: 2017



Detection of alpha1-antitrypsin deficiency in a European country without national registry yet
Source: International Congress 2016 – Role of genetics and exposures in COPD and asthma
Year: 2016

Protocol for the EARCO Registry: a pan-European observational study in patients with a1-antitrypsin deficiency
Source: ERJ Open Res, 6 (1) 00181-2019; 10.1183/23120541.00181-2019
Year: 2020



Genotyping and phenotyping of alpha1-antitrypsin deficiency Greek patients under augmentation therapy: a multicenter study
Source: Virtual Congress 2020 – Monitoring of inflammation in remodelling
Year: 2020


Risk of cancer in individuals with severe alpha-1-antitrypsin deficiency (PiZZ) compared with the Swedish general population
Source: Virtual Congress 2020 – Asthma and COPD: How genetic and environment influences its developement?
Year: 2020


Clinical and functional characteristics of Italian and Spanish patients with alpha 1-antitrypsin deficiency
Source: Annual Congress 2012 - COPD: epidemiology and varia
Year: 2012

Characteristics of zz alpha-1 antitrypsin deficiency patients on the Irish national registry
Source: Annual Congress 2012 - Inflammation in airway diseases: diagnosis and management
Year: 2012

What makes Alpha1-antitrypsin deficiency patients exacerbate: a 5-year cohort
Source: Virtual Congress 2021 – Biomarkers to phenotype COPD: prediction of exacerbations
Year: 2021


Baseline characteristics of patients enrolled in the EARCO prospective registry of alpha-1 antitrypsin deficiency: preliminary results.
Source: Virtual Congress 2021 – Treatments for airway diseases
Year: 2021


Diagnosis and management of a1-antitrypsin deficiency in Europe: an expert survey
Source: ERJ Open Res, 5 (1) 00171-2018; 10.1183/23120541.00171-2018
Year: 2019



Association of HLA variants with sarcoidosis in Korean population: pilot study
Source: Virtual Congress 2020 – Genetics and biomarkers for diagnosis and prognosis of granulomatous lung diseases
Year: 2020


Alpha-1-antitrypsin deficiency in Kazakh subjects with COPD
Source: International Congress 2016 – Biomarkers and phenotypes of COPD
Year: 2016


The incidence of alpha-1-antitrypsin (A1AT) deficiency alleles in Polish population – Results from the ongoing newborn screening
Source: Annual Congress 2013 –Translational research to bridge the need within clinical decision making
Year: 2013


Identification and analysis of clinical phenotypes in COPD patients: PALOMB Cohort
Source: Virtual Congress 2021 – COPD burden, epidemiology and management
Year: 2021


Baseline characteristics of subjects with α1-antitrypsin deficiency included in the alpha one international registry (AIR)
Source: Eur Respir J 2003; 22: Suppl. 45, 487s
Year: 2003

Trends in diagnosis and clinical presentation of alpha-1 antitrypsin deficiency within an Irish population
Source: Annual Congress 2012 - Inflammation in airway diseases: diagnosis and management
Year: 2012